March Emerging Medical Technologies Report

Table of Contents

BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED

• A soft, flexible, bandage-like patch pump for active and simultaneous subcutaneous delivery of one or more medications, including insulin
• A technology which involves a series of self-assembling magnets for incision-less bypass procedures within the digestive system
• Advanced visualization technology for surgery
• An FDA Class I, external neuro-stimulation medical device clinically shown to immediately reduce the blood pressure of hypertensive patients, via controlled cold therapy
• An innovative infusion pump which will provide totally accurate delivery of prescribed drugs to people suffering from chronic illnesses such as diabetes and neurodegenerative diseases
• Antimicrobial orthopedic implants for the prevention and treatment of bone-based infections
• Biomaterials that stimulate the regeneration of bone by a novel mechanism known as osteoinductive nanoarchitecture
• Corneal lens implant for the treatment of presbyopia, the age-related loss of the ability to read or focus on near objects
• Diagnosis devices that measure ocular motility
• Endoscopic vein harvesting technology
• Hand-held device and secured web service-based platform enabling anyone anywhere to perform an accurate physical examination for remote diagnosis
• Image-guided non-invasive brain stimulation
• Injectable silk hydrogel for the treatment of osteoarthritis
• Medical device technologies to improve outcomes in transcatheter aortic valve replacement procedures
• Miniaturized implantable neuromodulation technology; lead products are directed toward a number of clinical indications including the treatment of chronic pain and overactive bladder
• Molecular diagnostic device for the rapid detection of sepsis or other infection, to reduce unnecessary antibiotic use, and boost patient outcomes and healthcare facility efficiency
• Molecular diagnostics test focused on detecting sepsis in critical care patients
• Noninvasive solutions for people with sleep disordered breathing, that work by creating expiratory positive airway pressure
• Noninvasive treatment for acute and chronic kidney disease using low frequency therapeutic ultrasound
• One-step, point-of-care diagnostic that uses proprietary chemistry to measure enzymes to help clinicians determine how to treat chronic (or non-healing) wounds
• Ophthalmic drug delivery technology
• Ophthalmic surgical devices and instrumentation
• Optical imaging technology used during cancer surgery
• Point-of-care device that can rapidly detect and diagnose trauma-induced coagulopathy
• Simple fluid flow control module that can be incorporated within finished medical products, such as intravenous infusion pumps, enteral feeding devices, and patient monitoring systems
• State-of-the-art products for corneal cross-linking of corneal collagen fibers by combined riboflavin/UVA illumination for the treatment of progressive keratoconus
• Synthetic bone substitute
• Technologies that minimize peak skin interface pressures to prevent and expedite treatment of pressure ulcers/sores
• Temporary cardiac pacing device to treat reversible symptomatic bradycardia
• Wound treatment system which facilitates timely cleaning of trauma wounds such as road rash